quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:35·57d
SECFiling
Soleno Therapeutics Inc. logo

Soleno Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SLNO· Soleno Therapeutics Inc.
Health Care
Original source

Companies

  • SLNO
    Soleno Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Nov 18UpdateWolfe Research$75.00
  • Oct 7UpdateGoldman$125.00
  • Aug 20UpdateWells Fargo$123.00
  • Jun 23UpdateTD Cowen$110.00
  • Mar 5UpdateStifel$74.00
  • Dec 2UpdateStifel$74.00

Related

  • SEC3d
    SEC Form SC 14D9 filed by Soleno Therapeutics Inc.
  • SEC3d
    SEC Form SC TO-T filed by Soleno Therapeutics Inc.
  • PR8d
    Folia Health Launches "BRAVE-PWS" Study to Better Understand the Real-World Experience of Prader-Willi Syndrome Caregivers
  • SEC16d
    SEC Form 8-K filed by Soleno Therapeutics Inc.
  • SEC17d
    SEC Form SC14D9C filed by Soleno Therapeutics Inc.
  • SEC17d
    SEC Form SC TO-C filed by Soleno Therapeutics Inc.
  • SEC17d
    Soleno Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure
  • SEC17d
    SEC Form SC TO-C filed by Soleno Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022